BiotechTube
Home/Allyx Therapeutics/Stephen Strittmatter, MD, PhD
SS

Stephen Strittmatter, MD, PhD

Scientific Founder

Allyx Therapeutics

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseNeurodegenerative Diseases

Allyx Therapeutics Pipeline

DrugIndicationPhase
ALX-001Alzheimer's DiseasePhase 1b

Leadership Team at Allyx Therapeutics

SB
Stephen Bloch, MD
CEO, Co-Founder
TS
Timothy Siegert, PhD
COO, Co-Founder
View full Allyx Therapeutics profile